- Home
- CANF vs ATER Comparison
CANF vs ATER Comparison
Compare CANF & ATER Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CANF
- ATER
- Stock Information
- Founded
- CANF 1994
- ATER 2014
- Country
- CANF Israel
- ATER United States
- Employees
- CANF N/A
- ATER N/A
- Industry
- CANF Biotechnology: Pharmaceutical Preparations
- ATER Home Furnishings
- Sector
- CANF Health Care
- ATER Consumer Discretionary
- Exchange
- CANF Nasdaq
- ATER Nasdaq
- Market Cap
- CANF 14.8M
- ATER 15.5M
- IPO Year
- CANF N/A
- ATER N/A
- Fundamental
- Price
- CANF $1.03
- ATER $1.66
- Analyst Decision
- CANF Strong Buy
- ATER
- Analyst Count
- CANF 2
- ATER 0
- Target Price
- CANF $14.00
- ATER N/A
- AVG Volume (30 Days)
- CANF 129.3K
- ATER 243.8K
- Earning Date
- CANF 04-14-2025
- ATER 08-07-2025
- Dividend Yield
- CANF N/A
- ATER N/A
- EPS Growth
- CANF N/A
- ATER N/A
- EPS
- CANF N/A
- ATER N/A
- Revenue
- CANF $674,000.00
- ATER $94,191,000.00
- Revenue This Year
- CANF $461.72
- ATER N/A
- Revenue Next Year
- CANF N/A
- ATER $7.48
- P/E Ratio
- CANF N/A
- ATER N/A
- Revenue Growth
- CANF N/A
- ATER N/A
- 52 Week Low
- CANF $0.98
- ATER $1.22
- 52 Week High
- CANF $4.69
- ATER $3.84
- Technical
- Relative Strength Index (RSI)
- CANF 39.89
- ATER 58.30
- Support Level
- CANF $1.02
- ATER $1.34
- Resistance Level
- CANF $1.09
- ATER $1.52
- Average True Range (ATR)
- CANF 0.04
- ATER 0.13
- MACD
- CANF -0.00
- ATER 0.05
- Stochastic Oscillator
- CANF 6.67
- ATER 88.00
About CANF Can-Fite Biopharma Ltd Sponsored ADR (Israel)
Can Fite Biofarma Ltd is an clinical-stage biopharmaceutical company. The company develops orally bioavailable small molecule therapeutic products for the treatment of cancer, liver and inflammatory diseases and erectile dysfunction. The company's platform technology utilizes the Gi protein associated A3 adenosine receptor, or A3AR, as a therapeutic target. The company's drug candidate, Piclidenoson, is currently in a Phase III trial for psoriasis. Can-Fite's liver drug, Namodenoson, is headed into a Phase III trial for hepatocellular carcinoma (HCC), the common form of liver cancer, and a Phase IIb trial for the treatment of non-alcoholic steatohepatitis (NASH).
About ATER Aterian Inc.
Aterian Inc is a technology-enabled consumer products company. Its product categories include home and kitchen appliances, kitchenware, environmental appliances (dehumidifiers and air conditioners), beauty-related products and, consumer electronics. It has various owned and operates brands, including HomeLabs, Squatty Potty, Healing Solutions, PurSteam, and others. The company generates revenue through the online sales of various consumer products that are sold online.